Century Therapeutics Closes $160M Series C Financing

04 Mar, 2021

Century Therapeutics Closes $160M Series C Financing
Photo by Timon Studler on Unsplash

– Century Therapeutics, a Philadelphia, PA-based cell therapy company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, closed a $160m Series C financing.
– The round was led by Casdin Capital and brought together a syndicate of new investors including Fidelity Management & Research LLC, the Federated Hermes Kauffmann Funds, RA Capital, Logos Capital, OrbiMed, Marshall Wace, Qatar Investment Authority, Avidity Partners, and Octagon Capital.
– Eli Casdin, Founder and Chief Investment Officer of Casdin Capital will be joining the Century Therapeutics Board of Directors.

Biotechnology Health Care Health Diagnostics North America Therapeutics
Crunchbase icon

Content report

The following text will be sent to our editors: